nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—OPRD1—epilepsy syndrome	0.408	0.567	CbGaD
Alvimopan—OPRM1—epilepsy syndrome	0.312	0.434	CbGaD
Alvimopan—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00613	0.143	CbGeAlD
Alvimopan—OPRD1—ganglion—epilepsy syndrome	0.0056	0.13	CbGeAlD
Alvimopan—OPRM1—ganglion—epilepsy syndrome	0.00382	0.0887	CbGeAlD
Alvimopan—OPRD1—forebrain—epilepsy syndrome	0.00235	0.0546	CbGeAlD
Alvimopan—OPRK1—forebrain—epilepsy syndrome	0.00225	0.0523	CbGeAlD
Alvimopan—OPRD1—telencephalon—epilepsy syndrome	0.00216	0.0502	CbGeAlD
Alvimopan—OPRM1—brainstem—epilepsy syndrome	0.00166	0.0386	CbGeAlD
Alvimopan—Connective tissue disorder—Primidone—epilepsy syndrome	0.00165	0.0143	CcSEcCtD
Alvimopan—OPRM1—forebrain—epilepsy syndrome	0.0016	0.0372	CbGeAlD
Alvimopan—OPRM1—telencephalon—epilepsy syndrome	0.00147	0.0342	CbGeAlD
Alvimopan—Malnutrition—Primidone—epilepsy syndrome	0.00146	0.0126	CcSEcCtD
Alvimopan—Hypokalaemia—Acetazolamide—epilepsy syndrome	0.00137	0.0119	CcSEcCtD
Alvimopan—Anaemia—Primidone—epilepsy syndrome	0.00135	0.0117	CcSEcCtD
Alvimopan—OPRD1—head—epilepsy syndrome	0.00134	0.0313	CbGeAlD
Alvimopan—Urinary retention—Propofol—epilepsy syndrome	0.00133	0.0115	CcSEcCtD
Alvimopan—OPRK1—head—epilepsy syndrome	0.00129	0.03	CbGeAlD
Alvimopan—OPRD1—nervous system—epilepsy syndrome	0.00127	0.0296	CbGeAlD
Alvimopan—Urinary tract disorder—Rufinamide—epilepsy syndrome	0.00126	0.011	CcSEcCtD
Alvimopan—Urethral disorder—Rufinamide—epilepsy syndrome	0.00125	0.0109	CcSEcCtD
Alvimopan—Urinary retention—Fosphenytoin—epilepsy syndrome	0.00124	0.0107	CcSEcCtD
Alvimopan—OPRD1—central nervous system—epilepsy syndrome	0.00123	0.0285	CbGeAlD
Alvimopan—OPRK1—nervous system—epilepsy syndrome	0.00122	0.0284	CbGeAlD
Alvimopan—Urinary retention—Diazepam—epilepsy syndrome	0.00119	0.0103	CcSEcCtD
Alvimopan—Anileridine—OPRM1—epilepsy syndrome	0.00119	0.26	CrCbGaD
Alvimopan—Hypokalaemia—Fosphenytoin—epilepsy syndrome	0.00118	0.0103	CcSEcCtD
Alvimopan—Connective tissue disorder—Lacosamide—epilepsy syndrome	0.00118	0.0102	CcSEcCtD
Alvimopan—OPRK1—central nervous system—epilepsy syndrome	0.00118	0.0274	CbGeAlD
Alvimopan—Indinavir—SLCO1A2—epilepsy syndrome	0.00116	0.255	CrCbGaD
Alvimopan—OPRK1—cerebellum—epilepsy syndrome	0.00115	0.0267	CbGeAlD
Alvimopan—Urinary retention—Felbamate—epilepsy syndrome	0.00115	0.00997	CcSEcCtD
Alvimopan—Urinary retention—Zonisamide—epilepsy syndrome	0.00113	0.00976	CcSEcCtD
Alvimopan—Malnutrition—Rufinamide—epilepsy syndrome	0.00111	0.00967	CcSEcCtD
Alvimopan—Hypokalaemia—Felbamate—epilepsy syndrome	0.0011	0.00955	CcSEcCtD
Alvimopan—Urinary retention—Clonazepam—epilepsy syndrome	0.00108	0.00941	CcSEcCtD
Alvimopan—Back pain—Rufinamide—epilepsy syndrome	0.00108	0.00935	CcSEcCtD
Alvimopan—Urinary retention—Phenytoin—epilepsy syndrome	0.00108	0.00935	CcSEcCtD
Alvimopan—Hypokalaemia—Zonisamide—epilepsy syndrome	0.00108	0.00934	CcSEcCtD
Alvimopan—OPRM1—midbrain—epilepsy syndrome	0.00106	0.0246	CbGeAlD
Alvimopan—Constipation—Amobarbital—epilepsy syndrome	0.00106	0.00916	CcSEcCtD
Alvimopan—OPRM1—spinal cord—epilepsy syndrome	0.00103	0.024	CbGeAlD
Alvimopan—Hypokalaemia—Phenytoin—epilepsy syndrome	0.00103	0.00895	CcSEcCtD
Alvimopan—Flatulence—Lacosamide—epilepsy syndrome	0.00103	0.00894	CcSEcCtD
Alvimopan—Anaemia—Rufinamide—epilepsy syndrome	0.00103	0.00894	CcSEcCtD
Alvimopan—Urinary retention—Carbamazepine—epilepsy syndrome	0.00103	0.00892	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Primidone—epilepsy syndrome	0.00103	0.00891	CcSEcCtD
Alvimopan—Hypokalaemia—Oxcarbazepine—epilepsy syndrome	0.00103	0.0089	CcSEcCtD
Alvimopan—Malnutrition—Clobazam—epilepsy syndrome	0.00102	0.00881	CcSEcCtD
Alvimopan—Urinary retention—Lamotrigine—epilepsy syndrome	0.000994	0.00862	CcSEcCtD
Alvimopan—Hypokalaemia—Carbamazepine—epilepsy syndrome	0.000984	0.00854	CcSEcCtD
Alvimopan—OPRD1—brain—epilepsy syndrome	0.000974	0.0227	CbGeAlD
Alvimopan—Anaemia—Lacosamide—epilepsy syndrome	0.000967	0.00839	CcSEcCtD
Alvimopan—Anaemia—Clobazam—epilepsy syndrome	0.000939	0.00814	CcSEcCtD
Alvimopan—OPRK1—brain—epilepsy syndrome	0.000934	0.0217	CbGeAlD
Alvimopan—Connective tissue disorder—Midazolam—epilepsy syndrome	0.000929	0.00806	CcSEcCtD
Alvimopan—Connective tissue disorder—Levetiracetam—epilepsy syndrome	0.000917	0.00795	CcSEcCtD
Alvimopan—OPRM1—head—epilepsy syndrome	0.000917	0.0213	CbGeAlD
Alvimopan—OPRM1—nervous system—epilepsy syndrome	0.000869	0.0202	CbGeAlD
Alvimopan—Connective tissue disorder—Vigabatrin—epilepsy syndrome	0.000863	0.00748	CcSEcCtD
Alvimopan—Urinary tract disorder—Diazepam—epilepsy syndrome	0.000854	0.0074	CcSEcCtD
Alvimopan—Urethral disorder—Diazepam—epilepsy syndrome	0.000847	0.00735	CcSEcCtD
Alvimopan—OPRM1—central nervous system—epilepsy syndrome	0.000837	0.0195	CbGeAlD
Alvimopan—Malnutrition—Levetiracetam—epilepsy syndrome	0.000812	0.00705	CcSEcCtD
Alvimopan—Urinary tract disorder—Zonisamide—epilepsy syndrome	0.000809	0.00701	CcSEcCtD
Alvimopan—Connective tissue disorder—Zonisamide—epilepsy syndrome	0.000805	0.00698	CcSEcCtD
Alvimopan—Urethral disorder—Zonisamide—epilepsy syndrome	0.000803	0.00696	CcSEcCtD
Alvimopan—Dyspepsia—Rufinamide—epilepsy syndrome	0.000801	0.00695	CcSEcCtD
Alvimopan—Constipation—Phenobarbital—epilepsy syndrome	0.000792	0.00687	CcSEcCtD
Alvimopan—Back pain—Levetiracetam—epilepsy syndrome	0.000786	0.00682	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000785	0.00681	CcSEcCtD
Alvimopan—Urinary tract disorder—Clonazepam—epilepsy syndrome	0.000779	0.00676	CcSEcCtD
Alvimopan—Constipation—Rufinamide—epilepsy syndrome	0.000778	0.00675	CcSEcCtD
Alvimopan—Connective tissue disorder—Clonazepam—epilepsy syndrome	0.000775	0.00673	CcSEcCtD
Alvimopan—Urethral disorder—Clonazepam—epilepsy syndrome	0.000774	0.00671	CcSEcCtD
Alvimopan—Flatulence—Fosphenytoin—epilepsy syndrome	0.000773	0.0067	CcSEcCtD
Alvimopan—Connective tissue disorder—Phenytoin—epilepsy syndrome	0.00077	0.00668	CcSEcCtD
Alvimopan—Malnutrition—Vigabatrin—epilepsy syndrome	0.000764	0.00663	CcSEcCtD
Alvimopan—Back pain—Fosphenytoin—epilepsy syndrome	0.000758	0.00658	CcSEcCtD
Alvimopan—Malnutrition—Diazepam—epilepsy syndrome	0.000752	0.00653	CcSEcCtD
Alvimopan—Dyspepsia—Lacosamide—epilepsy syndrome	0.000752	0.00652	CcSEcCtD
Alvimopan—Back pain—Vigabatrin—epilepsy syndrome	0.000739	0.00641	CcSEcCtD
Alvimopan—Urinary tract disorder—Carbamazepine—epilepsy syndrome	0.000739	0.00641	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000737	0.0064	CcSEcCtD
Alvimopan—Connective tissue disorder—Carbamazepine—epilepsy syndrome	0.000735	0.00638	CcSEcCtD
Alvimopan—Urethral disorder—Carbamazepine—epilepsy syndrome	0.000733	0.00636	CcSEcCtD
Alvimopan—Constipation—Lacosamide—epilepsy syndrome	0.00073	0.00634	CcSEcCtD
Alvimopan—Back pain—Diazepam—epilepsy syndrome	0.000728	0.00631	CcSEcCtD
Alvimopan—Anaemia—Fosphenytoin—epilepsy syndrome	0.000725	0.00629	CcSEcCtD
Alvimopan—Flatulence—Felbamate—epilepsy syndrome	0.000718	0.00622	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.000716	0.00621	CcSEcCtD
Alvimopan—Urinary retention—Pregabalin—epilepsy syndrome	0.000714	0.00619	CcSEcCtD
Alvimopan—Malnutrition—Zonisamide—epilepsy syndrome	0.000713	0.00618	CcSEcCtD
Alvimopan—Connective tissue disorder—Lamotrigine—epilepsy syndrome	0.000711	0.00616	CcSEcCtD
Alvimopan—Constipation—Clobazam—epilepsy syndrome	0.000709	0.00615	CcSEcCtD
Alvimopan—Anaemia—Vigabatrin—epilepsy syndrome	0.000706	0.00613	CcSEcCtD
Alvimopan—Flatulence—Zonisamide—epilepsy syndrome	0.000702	0.00609	CcSEcCtD
Alvimopan—Anaemia—Diazepam—epilepsy syndrome	0.000695	0.00603	CcSEcCtD
Alvimopan—Malnutrition—Clonazepam—epilepsy syndrome	0.000687	0.00596	CcSEcCtD
Alvimopan—Hypokalaemia—Pregabalin—epilepsy syndrome	0.000683	0.00593	CcSEcCtD
Alvimopan—Malnutrition—Oxcarbazepine—epilepsy syndrome	0.000679	0.00589	CcSEcCtD
Alvimopan—Flatulence—Clonazepam—epilepsy syndrome	0.000677	0.00587	CcSEcCtD
Alvimopan—Anaemia—Felbamate—epilepsy syndrome	0.000673	0.00584	CcSEcCtD
Alvimopan—Flatulence—Phenytoin—epilepsy syndrome	0.000672	0.00583	CcSEcCtD
Alvimopan—Flatulence—Oxcarbazepine—epilepsy syndrome	0.000669	0.0058	CcSEcCtD
Alvimopan—Back pain—Clonazepam—epilepsy syndrome	0.000664	0.00576	CcSEcCtD
Alvimopan—OPRM1—brain—epilepsy syndrome	0.000664	0.0154	CbGeAlD
Alvimopan—Back pain—Phenytoin—epilepsy syndrome	0.00066	0.00573	CcSEcCtD
Alvimopan—Anaemia—Zonisamide—epilepsy syndrome	0.000659	0.00571	CcSEcCtD
Alvimopan—Back pain—Oxcarbazepine—epilepsy syndrome	0.000657	0.0057	CcSEcCtD
Alvimopan—Urinary retention—Gabapentin—epilepsy syndrome	0.000655	0.00568	CcSEcCtD
Alvimopan—Malnutrition—Carbamazepine—epilepsy syndrome	0.000651	0.00565	CcSEcCtD
Alvimopan—Dyspepsia—Acetazolamide—epilepsy syndrome	0.00065	0.00564	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	0.000638	0.00553	CcSEcCtD
Alvimopan—Anaemia—Clonazepam—epilepsy syndrome	0.000635	0.00551	CcSEcCtD
Alvimopan—Anaemia—Phenytoin—epilepsy syndrome	0.000631	0.00547	CcSEcCtD
Alvimopan—Back pain—Carbamazepine—epilepsy syndrome	0.00063	0.00547	CcSEcCtD
Alvimopan—Malnutrition—Lamotrigine—epilepsy syndrome	0.000629	0.00546	CcSEcCtD
Alvimopan—Flatulence—Lamotrigine—epilepsy syndrome	0.00062	0.00538	CcSEcCtD
Alvimopan—Back pain—Lamotrigine—epilepsy syndrome	0.000609	0.00528	CcSEcCtD
Alvimopan—Anaemia—Carbamazepine—epilepsy syndrome	0.000602	0.00522	CcSEcCtD
Alvimopan—Dyspepsia—Midazolam—epilepsy syndrome	0.000591	0.00513	CcSEcCtD
Alvimopan—Dyspepsia—Levetiracetam—epilepsy syndrome	0.000584	0.00506	CcSEcCtD
Alvimopan—Anaemia—Lamotrigine—epilepsy syndrome	0.000582	0.00505	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Midazolam—epilepsy syndrome	0.00058	0.00503	CcSEcCtD
Alvimopan—Constipation—Midazolam—epilepsy syndrome	0.000574	0.00498	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	0.000572	0.00497	CcSEcCtD
Alvimopan—Urinary tract disorder—Valproic Acid—epilepsy syndrome	0.000567	0.00492	CcSEcCtD
Alvimopan—Constipation—Levetiracetam—epilepsy syndrome	0.000567	0.00492	CcSEcCtD
Alvimopan—Connective tissue disorder—Valproic Acid—epilepsy syndrome	0.000565	0.0049	CcSEcCtD
Alvimopan—Urethral disorder—Valproic Acid—epilepsy syndrome	0.000563	0.00489	CcSEcCtD
Alvimopan—Dyspepsia—Fosphenytoin—epilepsy syndrome	0.000563	0.00489	CcSEcCtD
Alvimopan—Ketoprofen—SLCO1A2—epilepsy syndrome	0.000559	0.123	CrCbGaD
Alvimopan—Indinavir—ABCC2—epilepsy syndrome	0.000556	0.122	CrCbGaD
Alvimopan—Urinary retention—Topiramate—epilepsy syndrome	0.000551	0.00478	CcSEcCtD
Alvimopan—Dyspepsia—Vigabatrin—epilepsy syndrome	0.000549	0.00476	CcSEcCtD
Alvimopan—Constipation—Fosphenytoin—epilepsy syndrome	0.000547	0.00475	CcSEcCtD
Alvimopan—Dyspepsia—Diazepam—epilepsy syndrome	0.000541	0.00469	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	0.000538	0.00467	CcSEcCtD
Alvimopan—Constipation—Vigabatrin—epilepsy syndrome	0.000533	0.00463	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Diazepam—epilepsy syndrome	0.00053	0.0046	CcSEcCtD
Alvimopan—Hypokalaemia—Topiramate—epilepsy syndrome	0.000527	0.00457	CcSEcCtD
Alvimopan—Constipation—Diazepam—epilepsy syndrome	0.000525	0.00455	CcSEcCtD
Alvimopan—Dyspepsia—Felbamate—epilepsy syndrome	0.000523	0.00454	CcSEcCtD
Alvimopan—Urinary tract disorder—Pregabalin—epilepsy syndrome	0.000513	0.00445	CcSEcCtD
Alvimopan—Dyspepsia—Zonisamide—epilepsy syndrome	0.000512	0.00444	CcSEcCtD
Alvimopan—Connective tissue disorder—Pregabalin—epilepsy syndrome	0.00051	0.00443	CcSEcCtD
Alvimopan—Urethral disorder—Pregabalin—epilepsy syndrome	0.000509	0.00442	CcSEcCtD
Alvimopan—Constipation—Felbamate—epilepsy syndrome	0.000508	0.00441	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.000502	0.00436	CcSEcCtD
Alvimopan—Malnutrition—Valproic Acid—epilepsy syndrome	0.0005	0.00434	CcSEcCtD
Alvimopan—Constipation—Zonisamide—epilepsy syndrome	0.000497	0.00432	CcSEcCtD
Alvimopan—Dyspepsia—Clonazepam—epilepsy syndrome	0.000494	0.00428	CcSEcCtD
Alvimopan—Flatulence—Valproic Acid—epilepsy syndrome	0.000493	0.00428	CcSEcCtD
Alvimopan—Dyspepsia—Phenytoin—epilepsy syndrome	0.00049	0.00425	CcSEcCtD
Alvimopan—Dyspepsia—Oxcarbazepine—epilepsy syndrome	0.000488	0.00423	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000484	0.0042	CcSEcCtD
Alvimopan—Back pain—Valproic Acid—epilepsy syndrome	0.000484	0.0042	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000481	0.00417	CcSEcCtD
Alvimopan—Constipation—Clonazepam—epilepsy syndrome	0.000479	0.00416	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000478	0.00415	CcSEcCtD
Alvimopan—Constipation—Phenytoin—epilepsy syndrome	0.000476	0.00413	CcSEcCtD
Alvimopan—Constipation—Oxcarbazepine—epilepsy syndrome	0.000474	0.00411	CcSEcCtD
Alvimopan—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.00047	0.00408	CcSEcCtD
Alvimopan—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000468	0.00406	CcSEcCtD
Alvimopan—Dyspepsia—Carbamazepine—epilepsy syndrome	0.000468	0.00406	CcSEcCtD
Alvimopan—Urethral disorder—Gabapentin—epilepsy syndrome	0.000467	0.00405	CcSEcCtD
Alvimopan—Anaemia—Valproic Acid—epilepsy syndrome	0.000462	0.00401	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000459	0.00398	CcSEcCtD
Alvimopan—Constipation—Carbamazepine—epilepsy syndrome	0.000455	0.00394	CcSEcCtD
Alvimopan—Dyspepsia—Lamotrigine—epilepsy syndrome	0.000452	0.00392	CcSEcCtD
Alvimopan—Malnutrition—Pregabalin—epilepsy syndrome	0.000452	0.00392	CcSEcCtD
Alvimopan—Flatulence—Pregabalin—epilepsy syndrome	0.000446	0.00387	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000444	0.00385	CcSEcCtD
Alvimopan—Constipation—Lamotrigine—epilepsy syndrome	0.000439	0.00381	CcSEcCtD
Alvimopan—Back pain—Pregabalin—epilepsy syndrome	0.000437	0.00379	CcSEcCtD
Alvimopan—Anaemia—Pregabalin—epilepsy syndrome	0.000418	0.00363	CcSEcCtD
Alvimopan—Malnutrition—Gabapentin—epilepsy syndrome	0.000415	0.0036	CcSEcCtD
Alvimopan—Flatulence—Gabapentin—epilepsy syndrome	0.000409	0.00354	CcSEcCtD
Alvimopan—Back pain—Gabapentin—epilepsy syndrome	0.000401	0.00348	CcSEcCtD
Alvimopan—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000396	0.00343	CcSEcCtD
Alvimopan—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000394	0.00342	CcSEcCtD
Alvimopan—Urethral disorder—Topiramate—epilepsy syndrome	0.000393	0.00341	CcSEcCtD
Alvimopan—Indinavir—CYP2C19—epilepsy syndrome	0.000387	0.0848	CrCbGaD
Alvimopan—Anaemia—Gabapentin—epilepsy syndrome	0.000383	0.00332	CcSEcCtD
Alvimopan—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000359	0.00312	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000352	0.00306	CcSEcCtD
Alvimopan—Constipation—Valproic Acid—epilepsy syndrome	0.000349	0.00303	CcSEcCtD
Alvimopan—Malnutrition—Topiramate—epilepsy syndrome	0.000349	0.00303	CcSEcCtD
Alvimopan—Flatulence—Topiramate—epilepsy syndrome	0.000344	0.00298	CcSEcCtD
Alvimopan—Back pain—Topiramate—epilepsy syndrome	0.000337	0.00293	CcSEcCtD
Alvimopan—Anaemia—Topiramate—epilepsy syndrome	0.000322	0.0028	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000319	0.00276	CcSEcCtD
Alvimopan—Constipation—Pregabalin—epilepsy syndrome	0.000316	0.00274	CcSEcCtD
Alvimopan—Dyspepsia—Gabapentin—epilepsy syndrome	0.000298	0.00258	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000292	0.00253	CcSEcCtD
Alvimopan—Constipation—Gabapentin—epilepsy syndrome	0.000289	0.00251	CcSEcCtD
Alvimopan—Indinavir—CYP2D6—epilepsy syndrome	0.000287	0.0628	CrCbGaD
Alvimopan—Dyspepsia—Topiramate—epilepsy syndrome	0.000251	0.00217	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000246	0.00213	CcSEcCtD
Alvimopan—Constipation—Topiramate—epilepsy syndrome	0.000243	0.00211	CcSEcCtD
Alvimopan—Indinavir—ABCB1—epilepsy syndrome	0.000205	0.0449	CrCbGaD
Alvimopan—Ketoprofen—PTGS2—epilepsy syndrome	0.000116	0.0254	CrCbGaD
Alvimopan—Ketoprofen—ALB—epilepsy syndrome	0.000103	0.0226	CrCbGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR2—epilepsy syndrome	2.67e-05	0.000228	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—SST—epilepsy syndrome	2.67e-05	0.000228	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—OPRM1—epilepsy syndrome	2.65e-05	0.000226	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—HTR7—epilepsy syndrome	2.65e-05	0.000226	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AVP—epilepsy syndrome	2.64e-05	0.000225	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—POMC—epilepsy syndrome	2.62e-05	0.000224	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—ADRA2A—epilepsy syndrome	2.62e-05	0.000223	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.58e-05	0.00022	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL2—epilepsy syndrome	2.57e-05	0.000219	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.56e-05	0.000218	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—OPRD1—epilepsy syndrome	2.56e-05	0.000218	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GNAO1—epilepsy syndrome	2.56e-05	0.000218	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.53e-05	0.000216	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.53e-05	0.000216	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CHRM2—epilepsy syndrome	2.53e-05	0.000216	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT3—epilepsy syndrome	2.53e-05	0.000215	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL12—epilepsy syndrome	2.51e-05	0.000214	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—BDKRB2—epilepsy syndrome	2.51e-05	0.000214	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR3—epilepsy syndrome	2.51e-05	0.000214	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.51e-05	0.000214	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CDC42—epilepsy syndrome	2.48e-05	0.000211	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CNR1—epilepsy syndrome	2.47e-05	0.00021	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GABBR1—epilepsy syndrome	2.47e-05	0.00021	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PLCB1—epilepsy syndrome	2.46e-05	0.00021	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PDYN—epilepsy syndrome	2.45e-05	0.000209	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CHRM1—epilepsy syndrome	2.45e-05	0.000209	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR7—epilepsy syndrome	2.45e-05	0.000209	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GRM1—epilepsy syndrome	2.45e-05	0.000209	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NPY—epilepsy syndrome	2.44e-05	0.000208	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.44e-05	0.000208	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—HTR7—epilepsy syndrome	2.41e-05	0.000205	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AVP—epilepsy syndrome	2.4e-05	0.000204	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AGT—epilepsy syndrome	2.38e-05	0.000203	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HRH3—epilepsy syndrome	2.36e-05	0.000201	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HSPB1—epilepsy syndrome	2.36e-05	0.000201	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL3—epilepsy syndrome	2.36e-05	0.000201	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CRH—epilepsy syndrome	2.36e-05	0.000201	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL2—epilepsy syndrome	2.36e-05	0.000201	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—OXT—epilepsy syndrome	2.36e-05	0.000201	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.34e-05	0.000199	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—OPRM1—epilepsy syndrome	2.33e-05	0.000198	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR5—epilepsy syndrome	2.32e-05	0.000198	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.3e-05	0.000196	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GAL—epilepsy syndrome	2.3e-05	0.000196	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GFAP—epilepsy syndrome	2.3e-05	0.000196	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT3—epilepsy syndrome	2.29e-05	0.000196	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CASP2—epilepsy syndrome	2.28e-05	0.000194	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CHRM3—epilepsy syndrome	2.28e-05	0.000194	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GRM5—epilepsy syndrome	2.28e-05	0.000194	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.27e-05	0.000194	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AVP—epilepsy syndrome	2.23e-05	0.00019	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR3—epilepsy syndrome	2.2e-05	0.000187	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.2e-05	0.000187	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.2e-05	0.000187	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTK2B—epilepsy syndrome	2.19e-05	0.000187	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TSC1—epilepsy syndrome	2.19e-05	0.000187	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.18e-05	0.000186	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AGT—epilepsy syndrome	2.16e-05	0.000184	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.14e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CHRM2—epilepsy syndrome	2.14e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.14e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NPY—epilepsy syndrome	2.14e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.14e-05	0.000183	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SST—epilepsy syndrome	2.13e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NTRK2—epilepsy syndrome	2.13e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR2—epilepsy syndrome	2.13e-05	0.000182	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—DUSP6—epilepsy syndrome	2.11e-05	0.00018	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CDC42—epilepsy syndrome	2.09e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.09e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AGT—epilepsy syndrome	2.08e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GABBR1—epilepsy syndrome	2.08e-05	0.000178	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PLAT—epilepsy syndrome	2.08e-05	0.000177	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL3—epilepsy syndrome	2.07e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL2—epilepsy syndrome	2.07e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—OXT—epilepsy syndrome	2.07e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HSPB1—epilepsy syndrome	2.07e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CRH—epilepsy syndrome	2.07e-05	0.000176	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR5—epilepsy syndrome	2.04e-05	0.000174	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AVP—epilepsy syndrome	2.03e-05	0.000173	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—BDKRB2—epilepsy syndrome	2e-05	0.000171	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL12—epilepsy syndrome	2e-05	0.000171	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—POMC—epilepsy syndrome	2e-05	0.000171	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HRH3—epilepsy syndrome	2e-05	0.00017	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.99e-05	0.00017	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.99e-05	0.00017	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.99e-05	0.000169	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JUNB—epilepsy syndrome	1.97e-05	0.000168	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CNR1—epilepsy syndrome	1.97e-05	0.000168	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PLCB1—epilepsy syndrome	1.96e-05	0.000167	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.93e-05	0.000164	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TSC1—epilepsy syndrome	1.92e-05	0.000164	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTK2B—epilepsy syndrome	1.92e-05	0.000164	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HTR7—epilepsy syndrome	1.92e-05	0.000164	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.9e-05	0.000162	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AGT—epilepsy syndrome	1.89e-05	0.000161	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NTRK2—epilepsy syndrome	1.87e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SST—epilepsy syndrome	1.87e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR2—epilepsy syndrome	1.87e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HBEGF—epilepsy syndrome	1.86e-05	0.000159	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.86e-05	0.000158	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.86e-05	0.000158	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—DUSP6—epilepsy syndrome	1.85e-05	0.000158	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.83e-05	0.000156	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT3—epilepsy syndrome	1.83e-05	0.000156	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PLAT—epilepsy syndrome	1.82e-05	0.000155	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—POMC—epilepsy syndrome	1.82e-05	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NPY—epilepsy syndrome	1.81e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.81e-05	0.000154	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADAM10—epilepsy syndrome	1.79e-05	0.000152	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL2—epilepsy syndrome	1.78e-05	0.000152	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.76e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL12—epilepsy syndrome	1.76e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.76e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—POMC—epilepsy syndrome	1.75e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.75e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—OXT—epilepsy syndrome	1.75e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.75e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.75e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CRH—epilepsy syndrome	1.75e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.75e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.74e-05	0.000148	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JUNB—epilepsy syndrome	1.72e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CNR1—epilepsy syndrome	1.72e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.72e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PLCB1—epilepsy syndrome	1.72e-05	0.000146	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—S100B—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HTR7—epilepsy syndrome	1.68e-05	0.000143	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SOCS3—epilepsy syndrome	1.67e-05	0.000143	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CDC42—epilepsy syndrome	1.67e-05	0.000142	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HBEGF—epilepsy syndrome	1.63e-05	0.000139	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.63e-05	0.000139	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TSC1—epilepsy syndrome	1.62e-05	0.000138	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTK2B—epilepsy syndrome	1.62e-05	0.000138	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AVP—epilepsy syndrome	1.62e-05	0.000138	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT3—epilepsy syndrome	1.6e-05	0.000137	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AGT—epilepsy syndrome	1.6e-05	0.000136	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—POMC—epilepsy syndrome	1.59e-05	0.000136	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR2—epilepsy syndrome	1.58e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SST—epilepsy syndrome	1.58e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NTRK2—epilepsy syndrome	1.58e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADAM10—epilepsy syndrome	1.57e-05	0.000133	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—DUSP6—epilepsy syndrome	1.57e-05	0.000133	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL2—epilepsy syndrome	1.56e-05	0.000133	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.55e-05	0.000132	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLAT—epilepsy syndrome	1.54e-05	0.000131	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HES1—epilepsy syndrome	1.53e-05	0.00013	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FYN—epilepsy syndrome	1.49e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL12—epilepsy syndrome	1.48e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.48e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—POMC—epilepsy syndrome	1.48e-05	0.000126	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—S100B—epilepsy syndrome	1.48e-05	0.000126	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—H2AFX—epilepsy syndrome	1.48e-05	0.000126	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.48e-05	0.000126	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MEF2C—epilepsy syndrome	1.48e-05	0.000126	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.47e-05	0.000125	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SOCS3—epilepsy syndrome	1.47e-05	0.000125	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CDC42—epilepsy syndrome	1.46e-05	0.000125	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CNR1—epilepsy syndrome	1.46e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JUNB—epilepsy syndrome	1.46e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLCB1—epilepsy syndrome	1.45e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.43e-05	0.000122	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR7—epilepsy syndrome	1.42e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AVP—epilepsy syndrome	1.42e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NGF—epilepsy syndrome	1.41e-05	0.00012	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HBEGF—epilepsy syndrome	1.38e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR5—epilepsy syndrome	1.37e-05	0.000117	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT3—epilepsy syndrome	1.36e-05	0.000115	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—POMC—epilepsy syndrome	1.35e-05	0.000115	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HTR2A—epilepsy syndrome	1.34e-05	0.000115	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HES1—epilepsy syndrome	1.34e-05	0.000114	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADAM10—epilepsy syndrome	1.32e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL2—epilepsy syndrome	1.32e-05	0.000112	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FYN—epilepsy syndrome	1.3e-05	0.000111	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—H2AFX—epilepsy syndrome	1.3e-05	0.000111	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MEF2C—epilepsy syndrome	1.3e-05	0.00011	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TSC2—epilepsy syndrome	1.28e-05	0.000109	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGT—epilepsy syndrome	1.28e-05	0.000109	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.25e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—S100B—epilepsy syndrome	1.25e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOE—epilepsy syndrome	1.25e-05	0.000106	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.24e-05	0.000106	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NGF—epilepsy syndrome	1.24e-05	0.000106	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.24e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KDR—epilepsy syndrome	1.22e-05	0.000104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR5—epilepsy syndrome	1.2e-05	0.000103	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AVP—epilepsy syndrome	1.2e-05	0.000102	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HTR2A—epilepsy syndrome	1.18e-05	0.0001	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCB—epilepsy syndrome	1.18e-05	0.0001	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6ST—epilepsy syndrome	1.17e-05	0.0001	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HES1—epilepsy syndrome	1.13e-05	9.65e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TSC2—epilepsy syndrome	1.12e-05	9.54e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGT—epilepsy syndrome	1.12e-05	9.53e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FYN—epilepsy syndrome	1.1e-05	9.38e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.1e-05	9.35e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOE—epilepsy syndrome	1.1e-05	9.34e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.09e-05	9.33e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—POMC—epilepsy syndrome	1.07e-05	9.15e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KDR—epilepsy syndrome	1.07e-05	9.15e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.06e-05	9.02e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL2—epilepsy syndrome	1.05e-05	8.95e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NGF—epilepsy syndrome	1.05e-05	8.92e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCB—epilepsy syndrome	1.03e-05	8.81e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6ST—epilepsy syndrome	1.03e-05	8.77e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.02e-05	8.67e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR2A—epilepsy syndrome	9.96e-06	8.49e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FGF2—epilepsy syndrome	9.49e-06	8.09e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TSC2—epilepsy syndrome	9.46e-06	8.06e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGT—epilepsy syndrome	9.45e-06	8.05e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—POMC—epilepsy syndrome	9.41e-06	8.02e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOE—epilepsy syndrome	9.26e-06	7.89e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL2—epilepsy syndrome	9.21e-06	7.85e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KDR—epilepsy syndrome	9.07e-06	7.73e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RELA—epilepsy syndrome	8.81e-06	7.51e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCB—epilepsy syndrome	8.73e-06	7.44e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6ST—epilepsy syndrome	8.7e-06	7.41e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MTOR—epilepsy syndrome	8.64e-06	7.36e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FGF2—epilepsy syndrome	8.32e-06	7.09e-05	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.02e-06	6.84e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—POMC—epilepsy syndrome	7.95e-06	6.78e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CASP3—epilepsy syndrome	7.95e-06	6.77e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL2—epilepsy syndrome	7.78e-06	6.63e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RELA—epilepsy syndrome	7.73e-06	6.58e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	7.72e-06	6.58e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	7.58e-06	6.46e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	7.51e-06	6.4e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	7.28e-06	6.21e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	7.03e-06	6e-05	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.03e-06	5.99e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	6.97e-06	5.94e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	6.92e-06	5.9e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	6.77e-06	5.77e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	6.74e-06	5.75e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	6.58e-06	5.61e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	6.53e-06	5.57e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	6.4e-06	5.46e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	6.39e-06	5.44e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	6.07e-06	5.17e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	5.94e-06	5.07e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	5.91e-06	5.04e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	5.89e-06	5.02e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	5.72e-06	4.88e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	5.57e-06	4.74e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	5.4e-06	4.6e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	5.13e-06	4.37e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	5e-06	4.26e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	4.3e-06	3.67e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	3.77e-06	3.22e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	3.19e-06	2.72e-05	CbGpPWpGaD
